知镜 Cognispect · 医学文献与研究工作台

Executive summary of evidence-based clinical practice guideline for Fabry nephropathy.

Kim SH, Choi SJ, Park S, Cho E, Han SS, Koh ES, Chung BH, Jeong KH, Bae EH, Lee EY, Kim HJ, Kang HG, Lee BH, Kim JH, Hong GR, Park HD, Kwon YJ.
Kidney research and clinical practice · 2026-06-05 · PMID 42263771

文献摘要

The Academy of Fabry Disease in the Korean Society of Nephrology has developed evidence-based clinical practice guidelines to optimize the management and treatment of Fabry nephropathy. Although Fabry disease is a rare genetic disorder, the recent availability of effective therapeutic options, including enzyme replacement therapy and chaperone therapy, highlights the importance of early diagnosis and timely intervention. These guidelines were developed using the GRADE (Grading of Recommendations Assessment, Development and Evaluation) methodology, with support from methodology experts. Clinical recommendations were derived through a systematic literature review addressing 11 key questions. These guidelines are intended to assist healthcare professionals, including nephrologists, in making informed, evidence-based clinical decisions to improve patient outcomes.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。